Article Information
History
- April 13, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Khalidah A. Alenzi1,
- Hamdan S. Al-malky2,
- Ali F. Altebainawi3,4,
- Hamidah Q. Abushomi5,
- Fahad O. Alatawi6,
- Moosa H. Atwadi7,
- Moosa A. Khobrani8,
- Dlal A. Almazrou9,
- Nariman Alrubeh10,
- Zainab A. Alsoliabi10,
- Abdulaziz M. Kardam11,
- Shakr A. Alghamdi12,
- Abdulrahman Alasiri13 and
- Thamir M. Alshammari4,14,*
- 1Regional Drug Information Center, Ministry of Health, Tabuk, Saudi Arabia
- 2Regional Drug Information Center, Ministry of Health, Jeddah, Saudi Arabia
- 3Pharmaceutical Care Services, King Salman Specialist Hospital, Hail Health Cluster, Ministry of Health, Hail, Saudi Arabia
- 4Medication Safety Research Chair, King Saud University, Riyadh, Saudi Arabia
- 5Dammam medical complex, Eastern region cluster, Dammam, Saudi Arabia
- 6King Fahad Specialist hospital, Ministry of Health, Tabuk, Saudi Arabia
- 7Althager General Hospital, Ministry of Health, Jeddah, Saudi Arabia
- 8Prince Mohammed bin Nasser Hospital, Ministry of Health, Jizan, Saudi Arabia
- 9King Saud Medical City, Ministry of Health, Riyadh, Saudi Arabia
- 10Qatif Central Hospital, Ministry of Health, Eastern Region, Saudi Arabia
- 11King Faisal Medical City, Ministry of Health, Abha, Saudi Arabia
- 12Khamis Mushait General Hospital, Ministry of Health, Southern Region, Saudi Arabia
- 13Mohayl General Hospital, Ministry of Health, Asir, Saudi Arabia
- 14College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia
- ↵*Corresponding Author:
Thamir M. Alshammari, RPh, Ph. D, M.S, Advisor, Saudi Food and Drug Authority Executive President, Associate Professor of Pharmacy Practice, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia, Senior researcher, Medication Safety Research Chair, King Saud University, Vice-President, International Society of Pharmacovigilance Middle East, Riyadh, Saudi Arabia, Phone: +966505192886, Email: thamer.alshammary{at}gmail.com